http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05271224-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
filingDate 1992-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1993-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H05271224-A
titleOfInvention Novel oxetane ring-containing nucleoside derivative
abstract (57) [Summary] [Objective] To provide a novel oxetanosine ring-containing nucleoside derivative, which is expected as an active ingredient of pharmaceuticals such as antiviral agents and anticancer agents. [Constitution] General formula (2) [Chemical formula 1] [Wherein R 1 and R 2 are each independently a hydrogen atom or a hydroxyl group-protecting group, and X is a leaving group] is condensed with various nucleobase derivatives to form a protecting group on the resulting compound. If present, those protecting groups are optionally removed to give a compound of the general formula (1) A novel oxetane ring-containing nucleoside derivative represented by the formula [B is a nucleobase derivative and R 1 and R 2 each independently represent a hydrogen atom or a hydroxyl-protecting group] was produced.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007111075-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9234247-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4842983-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007105673-A1
priorityDate 1992-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410062813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410554345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452477813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3424274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409028757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86667330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451392314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454660418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450203074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32326

Total number of triples: 47.